Ovid Therapeutics, Inc. (OVID)

1.65 0.00 (0.00%) USD  |  NASDAQ  |  Jan 14, 16:00
1.64 -0.01 (-0.61%) Pre-Market: 08:20
More

Ovid Therapeutics Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for OVID.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
AnaptysBio, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
MannKind Corp. Upgrade
Cassava Sciences, Inc. --
Cogent Biosciences, Inc. --